Prenetics Global LTD Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NASDAQ
Hudson Blake Leogrande, a Director of Prenetics Global Ltd, reported multiple transactions in common stock on October 4, 2026.
NASDAQ
Hoi Chun Lo, Chief Financial Officer of Prenetics Global Ltd, reported multiple transactions in common stock on September 30, 2026.
NASDAQ
Hudson Blake Leogrande, a Director of Prenetics Global Ltd, reported multiple transactions in common stock on September 4, 2026.
NASDAQ
Thuan Yen Tat, VP, Finance of IM8 (US) LLC of Prenetics Global Ltd, received 10,730 shares of common stock on September 3, 2026.
NASDAQ
Brian J Rosin, CFO of IM8 (US) LLC of Prenetics Global Ltd, purchased 23,100 shares of common stock on August 24, 2026.
NASDAQ
Hoi Chun Lo, Chief Financial Officer of Prenetics Global Ltd, reported multiple transactions in common stock on August 21, 2026.
NASDAQ
Danny Sheng Wu Yeung, Chief Executive Officer and a Director of Prenetics Global Ltd, purchased 24,681 shares of common stock on August 20, 2026.
NASDAQ
Hudson Blake Leogrande, a Director of Prenetics Global Ltd, reported multiple transactions in common stock on August 4, 2026.
NASDAQ
Prenetics Global Ltd director Hudson Blake Leogrande acquired 2,000 Class A Ordinary Shares following the settlement of vested Restricted Stock Units.
NASDAQ
Prenetics Global Ltd reports that Director Cheng Yin Pan acquired 15,873 Class A Ordinary Shares following the settlement of vested Restricted Stock Units.
NASDAQ
Prenetics Global Ltd reports on director David Vanderveen's settlement of vested Restricted Stock Units and termination of services, resulting in the forfeiture of unvested awards.
NASDAQ
Director Cheng Yin Pan was granted 6,406 restricted stock units under the Prenetics Global Ltd 2022 Share Incentive Plan.
NASDAQ
Prenetics Global Ltd's Chief Financial Officer, Lo Hoi Chun, reported transactions involving Restricted Stock Units (RSUs) on May 19, 2026, detailing grants, vesting schedules, and beneficial ownership.